Transjugular intrahepatic portosystemic shunt in the treatment of Budd-Chiari syndrome: A critical review of literatures

Scandinavian Journal of Gastroenterology

Volumn 48, Issue 7, 2013, Pages 771-784

  Qi, Xingshun ^a   Yang, Man ^a   Fan, Daiming ^a,b   Han, Guohong ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Budd Chiari syndrome; Review; Transjugular intrahepatic portosystemic shunt; Treatment

Indexed keywords

BARE METAL STENT; BLEEDING; BUDD CHIARI SYNDROME; CAUSE OF DEATH; HEMODYNAMICS; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER FAILURE; LIVER VEIN THROMBOSIS; MORTALITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECANALIZATION; REVIEW; SURGICAL APPROACH; SURVIVAL RATE; SYSTEMATIC REVIEW; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME;

BUDD-CHIARI SYNDROME; EQUIPMENT FAILURE; HUMANS; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; POSTOPERATIVE COMPLICATIONS; STENTS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84880406359     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2013.777775     Document Type: Review

References (70)

1. Boyer TD, Haskal ZJ. The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. Hepatology 2005;41:386-400
2. Boyer TD, Haskal ZJ. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension: Update 2009. Hepatology 2010;51:306
3. Zheng M, Chen Y, Bai J, Zeng Q, You J, Jin R, et al. Transjugular intrahepatic portosystemic shunt versus endoscopic therapy in the secondary prophylaxis of variceal rebleeding in cirrhotic patients: Meta-analysis update. J Clin Gastroenterol 2008;42:507-16
4. Salerno F, Camma C, Enea M, Rossle M, Wong F. Transjugular intrahepatic portosystemic shunt for refractory ascites: A meta-analysis of individual patient data. Gastroenterology 2007;133:825-34
5. Lo GH, Liang HL, Chen WC, Chen MH, Lai KH, Hsu PI, et al. A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding. Endoscopy 2007;39:679-85
6. Garcia-Pagan JC, Caca K, Bureau C, LalemanW, Appenrodt B, Luca A, et al. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med 2010;362:2370-9
7. Monescillo A, Martinez-Lagares F, Ruiz-del-Arbol L, Sierra A, Guevara C, Jimenez E, et al. Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology 2004;40: 793-801
8. Dhanasekaran R, West JK, Gonzales PC, Subramanian R, Parekh S, Spivey JR, et al. Transjugular intrahepatic portosystemic shunt for symptomatic refractory hepatic hydrothorax in patients with cirrhosis. Am J Gastroenterol 2010;105: 635-41
9. Wong F, Pantea L, Sniderman K. Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome. Hepatology 2004;40:55-64
10. Qi X, Han G. Transjugular intrahepatic portosystemic shunt in the treatment of portal vein thrombosis : A critical review of literature. Hepatol Int 2012;6:576-90
11. Garcia-Pagan JC, Heydtmann M, Raffa S, Plessier A, Murad S, Fabris F, et al. TIPS for Budd-Chiari syndrome: Long-term results and prognostics factors in 124 patients. Gastroenterology 2008;135:808-15
12. Valla DC. Primary Budd-Chiari syndrome. J Hepatol 2009; 50:195-203
13. Okuda H, Yamagata H, Obata H, Iwata H, Sasaki R, Imai F, et al. Epidemiological and clinical features of Budd-Chiari syndrome in Japan. J Hepatol 1995;22:1-9
14. Valla DC. Hepatic venous outflow tract obstruction etiopathogenesis: Asia versus the West. J Gastroenterol Hepatol 2004;19:S204-11
15. DeLeve LD, Valla DC, Garcia-Tsao G. Vascular disorders of the liver. Hepatology 2009;49:1729-64
16. de Franchis R. Revising consensus in portal hypertension: Report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2010;53:762-8
17. Darwish Murad S, Plessier A, Hernandez-Guerra M, Fabris F, Eapen CE, Bahr MJ, et al. Etiology, management, and outcome of the Budd-Chiari syndrome. Ann Intern Med 2009;151:167-75
18. Plessier A, Sibert A, Consigny Y, Hakime A, Zappa M, Denninger MH, et al. Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome. Hepatology 2006;44:1308-16
19. Boyvat F, Harman A, Ozyer U, Aytekin C, Arat Z. Percutaneous sonographic guidance for TIPS in Budd-Chiari syndrome: Direct simultaneous puncture of the portal vein and inferior vena cava. AJR Am J Roentgenol 2008;191: 560-4
20. Molmenti EP, Segev DL, Arepally A, Hong J, Thuluvath PJ, Rai R, et al. The utility of TIPS in the management of Budd-Chiari syndrome. Ann Surg 2005;241:978-81; discussion 982-973
21. Zahn A, Gotthardt D, Weiss KH, Richter G, Schmidt J, Stremmel W, et al. Budd-Chiari syndrome: Long term success via hepatic decompression using transjugular intrahepatic porto-systemic shunt. BMC Gastroenterol 2010; 10:25
22. Safka V, Hulek P, Krajina A, Dulicek P, Fejfar T, Jirkovsky V, et al. Budd-Chiari syndrome and TIPS-twelve years' experience. Cas Lek Cesk 2005;144:38-42
23. Hernandez-Guerra M, Turnes J, Rubinstein P, Olliff S, Elias E, Bosch J, et al. PTFE-covered stents improve TIPS patency in Budd-Chiari syndrome. Hepatology 2004;40:1197-202
24. Wu X, Ding W, Cao J, Han J, Li J. Modified transjugular intrahepatic portosystemic shunt in the treatment of Budd- Chiari syndrome. Int J Clin Pract 2010;64:460-4
25. Mancuso A, Fung K, Mela M, Tibballs J, Watkinson A, Burroughs AK, et al. TIPS for acute and chronic Budd- Chiari syndrome: A single-centre experience. J Hepatol 2003; 38:751-4
26. Darwish Murad S, Luong TK, Pattynama PM, Hansen BE, van Buuren HR, Janssen HL. Long-term outcome of a covered vs. uncovered transjugular intrahepatic portosystemic shunt in Budd-Chiari syndrome. Liver Int 2008;28:249-56
27. Corso R, Intotero M, Solcia M, Castoldi MC, Rampoldi A. Treatment of Budd-Chiari syndrome with transjugular intrahepatic portosystemic shunt (TIPS). Radiol Med 2008;113: 727-38
28. Blum U, Rossle M, Haag K, Ochs A, Blum HE, Hauenstein KH, et al. Budd-Chiari syndrome: Technical, hemodynamic, and clinical results of treatment with transjugular intrahepatic portosystemic shunt. Radiology 1995;197: 805-11
29. Gandini R, Konda D, Simonetti G. Transjugular intrahepatic portosystemic shunt patency and clinical outcome in patients with Budd-Chiari syndrome: Covered versus uncovered stents. Radiology 2006;241:298-305
30. Rossle M, Olschewski M, Siegerstetter V, Berger E, Kurz K, Grandt D. The Budd-Chiari syndrome: Outcome after treatment with the transjugular intrahepatic portosystemic shunt. Surgery 2004;135:394-403
31. Wu XJ, Cao JM, Han JM, Li JS. Transjugular intrahepatic portosystemic shunt in the treatment of Budd-Chiari syndrome with extensive occlusion of the hepatic veins. Zhonghua Wai Ke Za Zhi 2006;44:1029-32
32. Han GH, He CY, Yin ZX, Meng XJ, Wang JH, Zhang HB, et al. Transjugular intrahepatic portosystemic shunt for the treatment of Budd-Chiari syndrome. J Intervent Radiol 2008;17:239-42
33. Rangarajan B, Jones C, Mangat K, Olliff S. TIPS for Budd- Chiari syndrome-a retrospective review of 50 cases with medium and long term follow up. Cardiovasc Intervent Radiol 2011;34:S7
34. Rangarajan B, Jones C, Mangat K, Olliff S. TIPS for Budd- Chiari syndrome: A retrospective review of 50 cases with medium and long term follow-up. J Vasc Interv Radiol 2012; 23:S95
35. Peltzer MY, Ring EJ, LaBerge JM, Haskal ZJ, Radosevich PM, Gordon RL. Treatment of Budd-Chiari syndrome with a transjugular intrahepatic portosystemic shunt. J Vasc Interv Radiol 1993;4:263-7
36. Ochs A, Sellinger M, Haag K, Noldge G, Herbst EW, Walter E, et al. Transjugular intrahepatic portosystemic stent-shunt (TIPS) in the treatment of Budd-Chiari syndrome. J Hepatol 1993;18:217-25
37. Walter E, Muntwyler J, Bertschinger P, Flury R, Ochs A, Haag K, et al. Trans-jugular intrahepatic portosystemic stent-shunt (TIPS) in a patient with Budd-Chiari syndrome. Schweiz Med Wochenschr 1993;123:1696-702
38. Peynircioglu B, Shorbagi AI, Balli O, Cil B, Balkanci F, Bayraktar Y. Is there an alternative to TIPS? Ultrasoundguided direct intrahepatic portosystemic shunt placement in Budd-Chiari syndrome. Saudi J Gastroenterol 2010;16:315- 18
39. Boyvat F, Aytekin C, Harman A, Ozin Y. Transjugular intrahepatic portosystemic shunt creation in Budd-Chiari syndrome: Percutaneous ultrasound-guided direct simultaneous puncture of the portal vein and vena cava. Cardiovasc Intervent Radiol 2006;29:857-61
40. Holland-Fischer P, Gronbaek H, Astrup L, Keiding S, Nielsen DT, Vilstrup H. Budd-Chiari and inferior caval vein syndromes due to membranous obstruction of the liver veins: Successful treatment with angioplasty and transcaval transjugular intrahepatic porto-systemic shunt. Scand J Gastroenterol 2004;39:1025-8
41. Fickert P, Trauner M, Hausegger K, Tauss J, Lackner H, Krejs GJ, et al. Intra-hepatic haematoma complicating transjugular intra-hepatic portosystemic shunt for Budd-Chiari syndrome associated with anti-phospholipid antibodies, aplastic anaemia and chronic hepatitis C. Eur J Gastroenterol Hepatol 2000;12:813-16
42. Ganguli SC, Ramzan NN, McKusick MA, Andrews JC, Phyliky RL, Kamath PS. Budd-Chiari syndrome in patients with hematological disease: A therapeutic challenge. Hepatology 1998;27:1157-61
43. Cejna M, Peck-Radosavljevic M, Schoder M, Thurnher S, Ba-Ssalamah A, Angermayr B, et al. Repeat interventions for maintenance of transjugular intrahepatic portosystemic shunt function in patients with Budd-Chiari syndrome. J Vasc Interv Radiol 2002;13:193-9
44. Surendrababu NR, Keshava SN, Eapen CE, Zachariah UG. Transjugular intrahepatic portocaval shunt placed through the strut of an inferior vena cava stent in a patient with Budd-Chiari syndrome: A technical modification. Br J Radiol 2010;83:e22-4
45. Qi X, He C, Han G, Yin Z, Wu F, Zhang Q, et al. Prevalence of paroxysmal nocturnal hemoglobinuria in Chinese patients with Budd-Chiari syndrome or portal vein thrombosis. J Gastroenterol Hepatol 2013;28:148-52
46. Qi X, Zhang C, Han G, Zhang W, He C, Yin Z, et al. Prevalence of the JAK2V617F mutation in Chinese patients with Budd-Chiari syndrome and portal vein thrombosis: A prospective study. J Gastroenterol Hepatol 2012;27: 1036-43
47. Nolte W, Figulla HR, Ringe B, Wiltfang J, Munke H, Hartmann H, et al. TIPSS in the Budd-Chiari syndrome with portal vein thrombosis. Dtsch Med Wochenschr 1997; 122:116-21
48. Leebeek FW, Lameris JS, van Buuren HR, Gomez E, Madretsma S, Sonneveld P. Budd-Chiari syndrome, portal vein and mesenteric vein thrombosis in a patient homozygous for factor V Leiden mutation treated by TIPS and thrombolysis. Br J Haematol 1998;102:929-31
49. Watanabe H, Shinzawa H, Saito T, Ishibashi M, Shirahata N, Miyano S, et al. Successful emergency treatment with a transjugular intrahepatic portosystemic shunt for life-threatening Budd-Chiari syndrome with portal thrombotic obstruction. Hepatogastroenterology 2000;47:839-41
50. Pfammatter T, Benoit C, Cathomas G, Blum U. Budd- Chiari syndrome with spleno-mesenteric-portal thrombosis: Treatment with extended TIPS. J Vasc Interv Radiol 2000;11: 781-4
51. Mancuso A, Watkinson A, Tibballs J, Patch D, Burroughs AK. Budd-Chiari syndrome with portal, splenic, and superior mesenteric vein thrombosis treated with TIPS: Who dares wins. Gut 2003;52:438
52. Opitz T, Buchwald AB, Lorf T, Awuah D, Ramadori G, Nolte W. The transjugular intrahepatic portosystemic stent- shunt (TIPS) as rescue therapy for complete Budd-Chiari syndrome and portal vein thrombosis. Z Gastroenterol 2003; 41:413-18
53. Kori I, Bar-Zohar D, Carmiel-Haggai M, Samuels D, Nakache R, Oren R, et al. Budd-Chiari syndrome and acute portal vein thrombosis: Management by a transjugular intrahepatic portosystemic shunt (TIPS) and portal vein interventions via a TIPS. J Gastrointest Surg 2006;10:417- 21
54. Verma A, Sharma G, Mohan S, Saraswat VA, Baijal SS. TIPS can be lifesaving in acute liver failure associated with portal vein and inferior vena cava thrombosis in a case of Budd Chiari syndrome due to protein S deficiency. Cardiovasc Intervent Radiol 2008;31:S197-9
55. Haskal ZJ. Power-pulse thrombolysis, thrombectomy, and TIPS formation for the accelerated treatment of portosplenomesenteric thrombosis in Budd-Chiari syndrome. J Vasc Interv Radiol 2007;18:1458-60
56. Sun Y, Ma X, Feng L, Guan S, Wang Z. Compensation by collateral circulation determines invasive therapeutic indications for patients with Budd-Chiari syndrome. Gut 2012;61: 1779-80
57. Han G, Qi X, Zhang W, He C, Yin Z, Wang J, et al. Percutaneous Recanalization for Budd-Chiari syndrome: An 11-year retrospective study on patency and survival in 177 Chinese Patients from a Single Center. Radiology 2013; 266:657-67
58. Hasegawa S, Eisenberg LB, Semelka RC. Active intrahepatic gadolinium extravasation following TIPS. Magn Reson Imaging 1998;16:851-3
59. Renc O, Krajina A, Lojik M, Chovanec V, Raupach J, Hulek P. An intrahepatic haematoma as a complication of TIPS procedure in a patient with Budd-Chiari syndrome. A case report. Cesk Radiol 2005;59:184-8
60. Lopez-Mendez E, Chavez-Tapia NC, Avila-Escobedo L, Cabrera-Aleksandrova T, Uribe M. Early experience of Budd-Chiari syndrome treatment with transjugular intrahepatic portosystemic shunt. Ann Hepatol 2006;5:157-60
61. Terreni N, Vangeli M, Raimondo ML, Tibballs JM, Patch D, Burroughs AK. Late intrahepatic hematoma complicating transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome. Cardiovasc Intervent Radiol 2007; 30:1065-9
62. Sze DY, Frisoli JK, Macksood DJ, Dovichi EA, Ahmed A, Keeffe EB. Progressive asymptomatic occlusion of a TIPS in a patient with Budd-Chiari syndrome. J Vasc Interv Radiol 2006;17:737-9
63. Blokzijl H, de Knegt RJ. Long-term effect of treatment of acute Budd-Chiari syndrome with a transjugular intrahepatic portosytemic shunt. Hepatology 2002;35:1551-2
64. Eldorry A, Barakat E, Abdella H, Abdelhakam S, Shaker M, Hamed A, et al. Outcome of non-surgical hepatic decompression procedures in Egyptian patients with Budd-Chiari. World J Gastroenterol 2011;17:906-13
65. Attwell A, LudkowskiM, Nash R, KugelmasM. Treatment of Budd-Chiari syndrome in a liver transplant unit, the role of transjugular intrahepatic porto-systemic shunt and liver transplantation. Aliment Pharmacol Ther 2004;20: 867-73
66. Lin EC. Peri-stent vascular channels after transjugular intrahepatic portosystemic shunt placement for Budd- Chiari syndrome: CT and US findings. Abdom Imaging 2001;26:191-3
67. Amarapurkar DN, Punamiya SJ, Patel ND. Changing spectrum of Budd-Chiari syndrome in India with special reference to non-surgical treatment. World J Gastroenterol 2008; 14:278-85
68. Eapen CE, Velissaris D, Heydtmann M, Gunson B, Olliff S, Elias E. Favourable medium term outcome following hepatic vein recanalisation and/or transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome. Gut 2006;55:878-84
69. Perello A, Garcia-Pagan JC, Gilabert R, Suarez Y, Moitinho E, Cervantes F, et al. TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy.Hepatology 2002;35:132-39
70. Gronbaek H, Neumann AK, Holland-Fischer P, Nielsen DT, Vilstrup HV. Budd-Chiari syndrome and TIPS treatment: Results from a Danish TIPS liver centre. Hepatology 2011;54:944A.